Clinical Trials Directory

Trials / Terminated

TerminatedNCT01696825

Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems

COMPARISON OF ABSORPTION OF VAGINAL DIAZEPAM USING DIFFERENT DELIVERY SYSTEMS

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Jason Gilleran · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine which of three delivery systems of vaginal diazepam have the best systemic absorption, measured by serum diazepam levels. The three delivery systems are: moistened tablet, suppository or cream. Additionally the study will compare the side effects and absorption of vaginal diazepam with oral diazepam. Vaginal diazepam is used off-label vaginally to relax pelvic floor muscles and reduce pelvic pain caused from pelvic floor dysfunction.

Conditions

Interventions

TypeNameDescription
DRUGDiazepam tablet, 5 mg, vaginalDiazepam tablet, 5 mg, moistened and inserted vaginally
DRUGDiazepam Suppository, 5 mg, vaginalCompounded diazepam 5 mg suppository administered vaginally
DRUGDiazepam Cream, 5 mg, VaginalCompounded diazepam cream, 5 mg, inserted vaginally

Timeline

Start date
2012-10-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2012-10-01
Last updated
2014-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01696825. Inclusion in this directory is not an endorsement.